4.6 Article

Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells

Related references

Note: Only part of the references are listed.
Article Pathology

Isolation and Characterization of Progenitor-Like Cells from Human Renal Proximal Tubules

David Lindgren et al.

AMERICAN JOURNAL OF PATHOLOGY (2011)

Article Multidisciplinary Sciences

Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappa B signalling

Vinagolu K. Rajasekhar et al.

NATURE COMMUNICATIONS (2011)

Article Oncology

Targeting breast stem cells with the cancer preventive compounds curcumin and piperine

Madhuri Kakarala et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Review Oncology

Potential for therapeutic targeting of tumor stem cells

Vaibhav Saini et al.

CANCER SCIENCE (2010)

Article Urology & Nephrology

Stem Cell Characteristics in Prostate Cancer Cell Lines

Minja J. Pfeiffer et al.

EUROPEAN UROLOGY (2010)

Article Otorhinolaryngology

SINGLE-MARKER IDENTIFICATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA CANCER STEM CELLS WITH ALDEHYDE DEHYDROGENASE

Matthew R. Clay et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)

Article Biochemistry & Molecular Biology

Targeting of Integrin β1 and Kinesin 2α by MicroRNA 183

Guorong Li et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Review Cell Biology

Cancer Stem Cells: A Stride Towards Cancer Cure?

Amitava Sengupta et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2010)

Article Medicine, Research & Experimental

ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome

Ting Li et al.

LABORATORY INVESTIGATION (2010)

Article Oncology

Cancer Statistics, 2009

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2009)

Review Oncology

Prostate cancer stem cells

S. H. Lang et al.

JOURNAL OF PATHOLOGY (2009)

Article Oncology

Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

Feng Jiang et al.

MOLECULAR CANCER RESEARCH (2009)

Review Biotechnology & Applied Microbiology

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

Bin-Bing S. Zhou et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Pathology

Stat3 promotes metastatic progression of prostate cancer

Junaid Abdulghani et al.

AMERICAN JOURNAL OF PATHOLOGY (2008)

Review Cell Biology

Prostate cancer and metastasis initiating stem cells

Kathleen Kelly et al.

CELL RESEARCH (2008)

Review Biochemistry & Molecular Biology

STAT3 as a target for cancer drug discovery

Luca Costantino et al.

CURRENT MEDICINAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Inflammation as the Primary Aetiological Agent of Human Prostate Cancer: A Stem Cell Connection?

Norman J. Maitland et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2008)

Review Oncology

Prostate cancer stem cells: A new target for therapy

Norman J. Maitland et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Cell & Tissue Engineering

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Christophe Ginestier et al.

CELL STEM CELL (2007)

Article Multidisciplinary Sciences

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

Jiangbing Zhou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Oncology

Small molecule inhibitors of Stat3 signaling pathway

Jinxia Deng et al.

CURRENT CANCER DRUG TARGETS (2007)

Article Oncology

Prospective identification of tumorigenic prostate cancer stem cells

AT Collins et al.

CANCER RESEARCH (2005)

Review Oncology

Targeting Stat3 in cancer therapy

N Jing et al.

ANTI-CANCER DRUGS (2005)

Article Biotechnology & Applied Microbiology

Synthesis of (-)-Galiellalactone

M Johansson et al.

JOURNAL OF ANTIBIOTICS (2002)

Review Multidisciplinary Sciences

Stem cells, cancer, and cancer stem cells

T Reya et al.

NATURE (2001)

Article Biochemistry & Molecular Biology

Inhibition of interleukin-6 signaling by galiellalactone

M Weidler et al.

FEBS LETTERS (2000)